Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-03-11
1997-09-30
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142378, 514311, 514331, 514332, 514341, 514365, 514396, 514406, 514432, 514445, 514451, 514602, 514604, 540524, 540531, 544 581, 544168, 544130, 544131, 544133, 546175, 546194, 546209, 546247, 546265, 5462834, 5462821, 546333, 546337, 5462804, 5462844, 5462817, 5462751, 548205, 5483351, 5483381, 549 13, 549 65, 549426, 564 84, 564 90, 564 92, 564 94, C07D21342, A61K 3144
Patent
active
056726155
ABSTRACT:
Disclosed are the compounds of formula I ##STR1## wherein R and R.sub.1 together with the chain to which they are attached or R.sub.1 and R.sub.2 together with the carbon atom to which they are attached form a ring; pharmaceutically acceptable prodrug derivatives and pharmaceutically salts thereof; methods of preparation thereof; pharmaceutical compositions comprising said compounds; and a method of inhibiting matrix-degrading metalloproteinase and of treating matrix-degrading metalloproteinase dependent conditions in mammals using such compounds.
REFERENCES:
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4885027 (1989-12-01), Pomidor
patent: 4996358 (1991-02-01), Handa er al.
patent: 5114953 (1992-05-01), Galardy et al.
patent: 5137914 (1992-08-01), Ohtani et al.
patent: 5240958 (1993-08-01), Campion et al.
Nature, vol. 370, Jul. 1994, pp. 218-220.
Nature, vol. 370, Aug. 1994, pp. 558-561.
Nature, vol. 370, Aug. 1994, pp. 555-557.
Bioesssays, vol. 14, No. 7-Jul. 1992, pp. 455-463.
Annual Reports in Medicinal Chemistry 25, pp. 177-184, 1989.
J. Med. Chem., 1989, 32, pp. 145-151.
Synthesis, 1985, pp. 929-931.
Chemical Abst. 93:81521r, 1980.
Chemical Abst. 59:3824a (1963).
Microchemical Journal, 40, pp. 226-232 (1989).
Chemical Abst. 70:88228j. 1959.
Chemical Abst. 59:3824b, 1963.
Trends Biotechnol., vol. 10, No. 6, 1992, pp. 200-207.
MacPherson Lawrence J.
Parker David Thomas
Davis Zinna Northington
Gruenfeld Norbert
Novartis Corporation
LandOfFree
Arylsulfonamido-substituted hydrodxamic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsulfonamido-substituted hydrodxamic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamido-substituted hydrodxamic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2256846